公司资料
Alkermes plc 股价、新闻与催化剂
- 股票代码:
- ALKS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Ireland
股票表现
44.54 USD (-2.94%)
收盘价
最后更新: 2026年11月5日
6.89B USD
市值
股价为何变动
最新公司动态“Alkermes Showcases Research From Psychiatry and Sleep Portfolios at the Neuroscience Education Institute Fall Congress”发布后，ALKS 于 2026年11月5日 收于 $44.54，较前一交易日下跌 2.94%。该变动发生在与这则公司动态对应的交易时段。
公司概览
业务概览
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
所在地与行业分类
Alkermes is headquartered in Ireland and listed on NASDAQ. It has a global footprint with a strong U.S. commercial base.
商业模式特征
The company generates value through product sales, neuroscience development, and lifecycle management across a specialty portfolio. Investors watch commercial execution, pipeline progress, and strategic allocation.
生物医药行业定位
Alkermes sits in the upper tier of specialty neuroscience biotech. It is more durable than a pure development-stage name, but catalyst events still matter to the story.
未来催化剂
- Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix. Investors will watch whether the commercial base stays durable.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。